These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9871538)

  • 1. (2S,4S)-amino-4-(2,2-diphenylethyl)pentanedioic acid selective group 2 metabotropic glutamate receptor antagonist.
    Escribano A; Ezquerra J; Pedregal C; Rubio A; Yruretagoyena B; Baker SR; Wright RA; Johnson BG; Schoepp DD
    Bioorg Med Chem Lett; 1998 Apr; 8(7):765-70. PubMed ID: 9871538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. (2S,4S)-2-amino-4-(4,4-diphenylbut-1-yl)- pentane-1,5-dioic acid: a potent and selective antagonist for metabotropic glutamate receptors negatively linked to adenylate cyclase.
    Wermuth CG; Mann A; Schoenfelder A; Wright RA; Johnson BG; Burnett JP; Mayne NG; Schoepp DD
    J Med Chem; 1996 Feb; 39(4):814-6. PubMed ID: 8632404
    [No Abstract]   [Full Text] [Related]  

  • 3. 1-Aminoindan-1,5-dicarboxylic acid: a novel antagonist at phospholipase C-linked metabotropic glutamate receptors.
    Pellicciari R; Luneia R; Costantino G; Marinozzi M; Natalini B; Jakobsen P; Kanstrup A; Lombardi G; Moroni F; Thomsen C
    J Med Chem; 1995 Sep; 38(19):3717-9. PubMed ID: 7562903
    [No Abstract]   [Full Text] [Related]  

  • 4. 2-Substituted (2SR)-2-amino-2-((1SR,2SR)-2-carboxycycloprop-1-yl)glycines as potent and selective antagonists of group II metabotropic glutamate receptors. 1. Effects of alkyl, arylalkyl, and diarylalkyl substitution.
    Ornstein PL; Bleisch TJ; Arnold MB; Wright RA; Johnson BG; Schoepp DD
    J Med Chem; 1998 Jan; 41(3):346-57. PubMed ID: 9464366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective antagonists at group I metabotropic glutamate receptors: synthesis and molecular pharmacology of 4-aryl-3-isoxazolol amino acids.
    Kromann H; Sløk FA; Stensbøl TB; Bräuner-Osborne H; Madsen U; Krogsgaard-Larsen P
    J Med Chem; 2002 Feb; 45(4):988-91. PubMed ID: 11831912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2-substituted (2SR)-2-amino-2-((1SR,2SR)-2-carboxycycloprop-1-yl)glycines as potent and selective antagonists of group II metabotropic glutamate receptors. 2. Effects of aromatic substitution, pharmacological characterization, and bioavailability.
    Ornstein PL; Bleisch TJ; Arnold MB; Kennedy JH; Wright RA; Johnson BG; Tizzano JP; Helton DR; Kallman MJ; Schoepp DD; Hérin M
    J Med Chem; 1998 Jan; 41(3):358-78. PubMed ID: 9464367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. (2S,1'S,2'S,3'R)-2-(2'-carboxy-3'-phenylcyclopropyl)glycine, a potent and selective antagonist of type 2 metabotropic glutamate receptors.
    Thomsen C; Bruno V; Nicoletti F; Marinozzi M; Pellicciari R
    Mol Pharmacol; 1996 Jul; 50(1):6-9. PubMed ID: 8700119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and pharmacology of 3-isoxazolol amino acids as selective antagonists at group I metabotropic glutamic acid receptors.
    Madsen U; Bräuner-Osborne H; Frydenvang K; Hvene L; Johansen TN; Nielsen B; Sánchez C; Stensbøl TB; Bischoff F; Krogsgaard-Larsen P
    J Med Chem; 2001 Mar; 44(7):1051-9. PubMed ID: 11297452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological activity of glutamic acid derivatives.
    Receveur JM; Guiramand J; Récasens M; Roumestant ML; Viallefont P; Martinez J
    Bioorg Med Chem Lett; 1998 Jan; 8(2):127-32. PubMed ID: 9871639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Definition of a pharmacophore for the metabotropic glutamate receptors negatively linked to adenylyl cyclase.
    Costantino G; Natalini B; Pellicciari R; Moroni F; Lombardi G
    Bioorg Med Chem; 1993 Oct; 1(4):259-65. PubMed ID: 7915955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, SARs, and pharmacological characterization of 2-amino-3 or 6-fluorobicyclo[3.1.0]hexane-2,6-dicarboxylic acid derivatives as potent, selective, and orally active group II metabotropic glutamate receptor agonists.
    Nakazato A; Kumagai T; Sakagami K; Yoshikawa R; Suzuki Y; Chaki S; Ito H; Taguchi T; Nakanishi S; Okuyama S
    J Med Chem; 2000 Dec; 43(25):4893-909. PubMed ID: 11123999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. (R,S)-4-phosphonophenylglycine, a potent and selective group III metabotropic glutamate receptor agonist, is anticonvulsive and neuroprotective in vivo.
    Gasparini F; Bruno V; Battaglia G; Lukic S; Leonhardt T; Inderbitzin W; Laurie D; Sommer B; Varney MA; Hess SD; Johnson EC; Kuhn R; Urwyler S; Sauer D; Portet C; Schmutz M; Nicoletti F; Flor PJ
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1678-87. PubMed ID: 10336568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New allosteric modulators of metabotropic glutamate receptor 5 (mGluR5) found by ligand-based virtual screening.
    Renner S; Noeske T; Parsons CG; Schneider P; Weil T; Schneider G
    Chembiochem; 2005 Apr; 6(4):620-5. PubMed ID: 15744765
    [No Abstract]   [Full Text] [Related]  

  • 14. Synthesis of phenylglycine derivatives as potent and selective antagonists of group III metabotropic glutamate receptors.
    Conway SJ; Miller JC; Howson PA; Clark BP; Jane DE
    Bioorg Med Chem Lett; 2001 Mar; 11(6):777-80. PubMed ID: 11277518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LY341495 is a nanomolar potent and selective antagonist of group II metabotropic glutamate receptors.
    Kingston AE; Ornstein PL; Wright RA; Johnson BG; Mayne NG; Burnett JP; Belagaje R; Wu S; Schoepp DD
    Neuropharmacology; 1998; 37(1):1-12. PubMed ID: 9680254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3-[Substituted]-5-(5-pyridin-2-yl-2H-tetrazol-2-yl)benzonitriles: identification of highly potent and selective metabotropic glutamate subtype 5 receptor antagonists.
    Tehrani LR; Smith ND; Huang D; Poon SF; Roppe JR; Seiders TJ; Chapman DF; Chung J; Cramer M; Cosford ND
    Bioorg Med Chem Lett; 2005 Nov; 15(22):5061-4. PubMed ID: 16183275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LY354740 is a potent and highly selective group II metabotropic glutamate receptor agonist in cells expressing human glutamate receptors.
    Schoepp DD; Johnson BG; Wright RA; Salhoff CR; Mayne NG; Wu S; Cockerman SL; Burnett JP; Belegaje R; Bleakman D; Monn JA
    Neuropharmacology; 1997 Jan; 36(1):1-11. PubMed ID: 9144636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of the glutamatergic metabotropic receptors in the regulation of glutamate uptake and extracellular excitatory amino acid levels in the striatum of chloral hydrate-anesthetized rats.
    Samuel D; Pisano P; Forni C; Nieoullon A; Kerkerian-Le Goff L
    Brain Res; 1996 Nov; 739(1-2):156-62. PubMed ID: 8955935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and structure-activity relationship studies of novel 2-diarylethyl substituted (2-carboxycycloprop-1-yl)glycines as high-affinity group II metabotropic glutamate receptor ligands.
    Sørensen US; Bleisch TJ; Kingston AE; Wright RA; Johnson BG; Schoepp DD; Ornstein PL
    Bioorg Med Chem; 2003 Jan; 11(2):197-205. PubMed ID: 12470714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2,3'-disubstituted-2-(2'-carboxycyclopropyl)glycines as potent and selective antagonists of metabotropic glutamate receptors.
    Collado I; Ezquerra J; Mazón A; Pedregal C; Yruretagoyena B; Kingston AE; Tomlinson R; Wright RA; Johnson BG; Schoepp DD
    Bioorg Med Chem Lett; 1998 Oct; 8(20):2849-54. PubMed ID: 9873635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.